Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$465K Buy
9,652
+1,115
+13% +$56.9K ﹤0.01% 1089
2026
Q2
$447K Sell
8,537
-348
-4% -$18.4K ﹤0.01% 1090
2026
Q1
$490K Sell
8,885
-1,602
-15% -$86.8K ﹤0.01% 859
2025
Q4
$514K Sell
10,487
-550
-5% -$25.7K ﹤0.01% 984
2025
Q3
$476K Sell
11,037
-605
-5% -$23.6K ﹤0.01% 962
2025
Q2
$447K Sell
11,642
-470
-4% -$18K ﹤0.01% 932
2025
Q1
$469K Buy
12,112
+1,437
+13% +$52.6K ﹤0.01% 802
2024
Q4
$361K Buy
10,675
+280
+3% +$10.1K ﹤0.01% 874
2024
Q3
$425K Sell
10,395
-953
-8% -$39K ﹤0.01% 831
2024
Q2
$437K Sell
11,348
-499
-4% -$21K ﹤0.01% 809
2024
Q1
$508K Sell
11,847
-1,228
-9% -$50.6K ﹤0.01% 767
2023
Q4
$485K Sell
13,075
-878
-6% -$31.5K ﹤0.01% 804
2023
Q3
$506K Sell
13,953
-2,554
-15% -$90.6K ﹤0.01% 766
2023
Q2
$588K Buy
+16,507
New +$592K 0.01% 750
2022
Q3
– Sell
-18,350
Closed -$998K – 1060
2022
Q2
$998K Sell
18,350
-3,168
-15% -$175K 0.01% 540
2022
Q1
$1.17M Sell
21,518
-9,686
-31% -$526K 0.01% 571
2021
Q4
$1.72M Buy
31,204
+98
+0.3% +$5.1K 0.01% 481
2021
Q3
$1.49M Buy
31,106
+4,163
+15% +$209K 0.01% 515
2021
Q2
$1.34M Sell
26,943
-778,172
-97% -$37.4M 0.01% 524
2021
Q1
$35.9M Sell
805,115
-6,697
-0.8% -$304K 0.27% 50
2020
Q4
$37.3M Buy
+811,812
New +$37.3M 0.24% 58

Other funds holding GSK

Vontobel Holding's GSK Position: Q3 2026 in Review

Vontobel Holding increased its GSK (GSK) stake by 13% in Q3 2026, buying an estimated $56.9K and bringing the position to 9,652 shares worth $465K. The position accounts for ﹤0.01% of the portfolio, ranked #1089.

Vontobel Holding first reported a position in GSK in Q4 2020 and has held it in 21 quarters since. The position peaked at $37.3M in Q4 2020. 602 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Vontobel Holding held 9,652 shares of GSK worth $465K as of Q3 2026.
  • Vontobel Holding bought 1,115 GSK shares in Q3 2026, an estimated $56.9K.
  • GSK made up ﹤0.01% of Vontobel Holding's portfolio in Q3 2026, its #1089 holding.
  • Vontobel Holding first reported a position in GSK in Q4 2020 and has held it in 21 quarters since.
  • Vontobel Holding's GSK position peaked at $37.3M in Q4 2020.
  • 602 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.